Hong Kong Biosimilar Requirements Kick In Jan. 1
This article was originally published in PharmAsia News
Executive Summary
Hong Kong has issued its first ever guidance on the evaluation and registration of biosimilar products, which will come into effect on Jan. 1, 2016.